Treatments of medical complications of anorexia nervosa and bulimia nervosa

Journal of Eating Disorders

Volumn 3, Issue 1, 2015, Pages

  Mehler, Philip S ^a   Krantz, Mori J ^a   Sachs, Katherine V ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Anorexia nervosa; Bulimia nervosa; Medical complications; Treatment

Indexed keywords

EID: 84941146456     PISSN: None     EISSN: 20502974     Source Type: Journal    
DOI: 10.1186/s40337-015-0041-7     Document Type: Review

References (49)

1. Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5) 2013, American Psychiatric Association, Arlington, VA.
2. Dalle Grave R, Calugi S, Marchesini G. Is amenorrhea a clinically useful criterion for the diagnosis of anorexia nervosa?. Behav Res Ther 2008, 46:1290-4. 10.1016/j.brat.2008.08.007, 18848697.
3. Golden NH, Jacobson MS, Schebendach J, Solanto MV, Hertz SM, Shenker IR. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 1997, 151:16-21. 10.1001/archpedi.1997.02170380020003, 9006523.
4. Swenne I. Weight requirements for return of menstruations in teenage girls with eating disorders, weight loss and secondary amenorrhoea. Acta Paediatr 2004, 93:1449-55. 10.1111/j.1651-2227.2004.tb02628.x, 15513571.
5. Miller KK, Parulekar MS, Schoenfeld E, Parulekar S, Anderson E, Hubbard J, et al. Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake. J Clin Endocrinol Metab 1998, 83:2309-12. 9661600.
6. Warren MP, Voussoughian F, Geer EB, Hyle EP, Adberg CL, Ramos RH. Functional hypothalamic amenorrhea: hypoleptinemia and disordered eating. J Clin Endocrinol Metab 1999, 84:873-7. 10.1210/jcem.84.3.5551, 10084564.
7. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004, 351:987-97. 10.1056/NEJMoa040388, 15342807.
8. Chou SH, Chamberland JP, Liu X, Matarese G, Gao C, Stefanakis R, et al. Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci U S A 2011, 108:6585-90. 10.1073/pnas.1015674108, 21464293.
9. Bergström I, Crisby M, Engström AM, Hölcke M, Fored M, Jakobsson Kruse P, et al. Women with anorexia nervosa should not be treated with estrogen or birth control pills in a bone-sparing effect. Acta Obstet Gynecol Scand 2013, 92:877-80. 10.1111/aogs.12178, 23682675.
10. Bulik CM, Hoffman ER, Von Holle A, Torgersen L, Stoltenberg C, Reichborn-Kjennerud T. Unplanned pregnancy in women with anorexia nervosa. Obstet Gynecol 2010, 116:1136-40. 10.1097/AOG.0b013e3181f7efdc, 20966699.
11. Kohmura H, Miyake A, Aono T, Tanizawa O. Recovery of reproductive function in patients with anorexia nervosa: a 10-year follow-up study. Eur J Obstet Gynecol Reprod Biol 1986, 22:293-6. 10.1016/0028-2243(86)90117-6, 3770278.
12. Koubaa S, Hällström T, Lindholm C, Hirschberg AL. Pregnancy and neonatal outcomes in women with eating disorders. Obstet Gynecol 2005, 105:255-60. 10.1097/01.AOG.0000148265.90984.c3, 15684148.
13. Katz MG, Vollenhoven B. The reproductive endocrine consequences of anorexia nervosa. BJOG 2000, 107:707-13. 10.1111/j.1471-0528.2000.tb13329.x, 10847224.
14. Lucas AR, Melton LJ, Crowson CS, O'Fallon WM. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 1999, 74:972-7. 10.1016/S0025-6196(11)63994-3, 10918862.
15. Baker D, Roberts R, Towell T. Factors predictive of bone mineral density in eating-disordered women: a longitudinal study. Int J Eat Disord 2000, 27:29-35. 10.1002/(SICI)1098-108X(200001)27:1<29::AID-EAT3>3.0.CO;2-P, 10590446.
16. Kraeft JJ, Uppot RN, Heffess AM. Imaging findings in eating disorders. AJR Am J Roentgenol 2013, 200:W328-35. 10.2214/AJR.12.9641, 23521475.
17. Grinspoon S, Thomas E, Pitts S, Gross E, Mickley D, Miller K, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 2000, 21:790-4. 10.7326/0003-4819-133-10-200011210-00011.
18. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002, 87:2883-91. 10.1210/jcem.87.6.8574, 12050268.
19. Golden NH, Iglesias EA, Jacobson MS, Carey D, Meyer W, Schebendach J, et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005, 90:3179-85. 10.1210/jc.2004-1659, 15784715.
20. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997, 82:2386-90. 10.1210/jcem.82.8.4163, 9253305.
21. Fazeli PK, Wang IS, Miller KK, Herzog DB, Misra M, Lee H, et al. Teriparatide increases bone duration in adult women with anorexia nervosa. J Clin Endocrinol Metab 2014, 99:1322-9. 10.1210/jc.2013-4105, 24456286.
22. Mehler PS, MacKenzie TD. Treatment of osteopenia and osteoporosis in anorexia nervosa: a systematic review of the literature. Int J Eat Disord 2009, 42:195-201. 10.1002/eat.20593, 18951456.
23. Miller KK, Grinspoon SK, Ciampa J, Hier J, Herzog D, Klibanski A. Medical findings in outpatients with anorexia nervosa. Arch Int Med 2005, 165:561-6. 10.1001/archinte.165.5.561.
24. Krantz MJ, Gaudianni J, Johnson V, Mehler PS. Exercise Electrocardiography extinguishes persistent junctional rhythm in a patient with severe anorexia nervosa. Cardiology 2011, 120:217-20. 10.1159/000335481, 22343463.
25. Krantz MJ, Sabel A, Sagar U, Long CS, Barbey JT, White K, et al. Factors influencing qt prolongation in hospitalized patients with severe anorexia nervosa. Gen Hosp Psychiatry 2011, 34:173-7. 10.1016/j.genhosppsych.2011.08.003, 21917317.
26. Melanson EL, Donahoo WT, Krantz MJ, Poirier P, Mehler PS. Resting and ambulatory hearth rate variability in chronic anorexia nervosa. Am J Cardiol 2004, 94:1217-20. 10.1016/j.amjcard.2004.07.103, 15518630.
27. Oflaz S, Yucel B, Oz F, Sahin D, Ozturk N, Yaci O, et al. Assessment of myocardial damage by cardiac MRI in patients with anorexia nervosa. Int J Eat Disord 2013, 46:862-6. 10.1002/eat.22170, 23922168.
28. Kamal N, Chami T, Andersen A, Rosell FA, Schuster MM, Whitehead WE. Delayed gastrointestinal transit times in anorexia nervosa and bulimia nervosa. Gastroenterology 1991, 101:1320-4. 1936803.
29. Benini L, Todesco T, Dalle Grave R, Deiorio F, Salandini L, Vantini I. Gastric emptying in patients with restricting and binge/purging subtypes of anorexia nervosa. Am J Gastroenterol 2004, 99:1448-54. 10.1111/j.1572-0241.2004.30246.x, 15307858.
30. Olansson EA, Storsrud S, Grundin H, Isaksson M, Altval S, Simren M. Small particle size diet reducing upper gastrointestinal symptoms in patients with diabetic gastroperesis. Am J Gastroenterol 2014, 109:375-85. 10.1038/ajg.2013.453.
31. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther 2010, 31:11-9. 10.1111/j.1365-2036.2009.04189.x, 19886950.
32. Kanji S, Stevenson A, Hutton B. Sudden cardiac death and ventricular arrhythmias associated with domperidone: evidence supporting health canada's warning. Can J Hosp Pharm 2014, 67:311-2. 25214665.
33. Richards RD, Davenport K, McCallum RW. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993, 88:203-7. 8424421.
34. Hines JR, Gore RM, Ballantyne GH. Superior mesenteric artery syndrome. Diagnostic criteria and therapeutic approaches. Am J Surg 1984, 148:630-2. 10.1016/0002-9610(84)90339-8, 6496852.
35. Mehler PS, Weiner KL. Use of total parenteral nutrition in the refeeding of selected patients with severe anorexia nervosa. Int J Eat Disord 2007, 40:285-7. 10.1002/eat.20371, 17262814.
36. Holmes SR, Gudridge TA, Gaudiani JL, Mehler PS. Dysphagia in severe anorexia nervosa: a case report. Int J Eat Disord 2012, 45:463-6. 10.1002/eat.20971, 22253066.
37. Chun AB, Sokol MS, Kaye WH, Hutson WR, Wald A. Colonic and anorectal function in constipated patients with anorexia nervosa. Am J Gastroenterol 1997, 92:1879-83. 9382057.
38. Mehler PS, Krantz M. Anorexia nervosa medical issues. J Womens Health 2003, 12:331-40. 10.1089/154099903765448844.
39. Morris LG, Stephenson KE, Herring S, Marti JL. Recurrent acute pancreatitis in anorexia and bulimia. JOP 2004, 5:231-4. 15254353.
40. Harris RH, Sasson G, Mehler PS. Elevation of liver function tests in severe anorexia nervosa. Int J Eat Disord 2013, 46:369-74. 10.1002/eat.22073, 23280717.
41. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American gastrointestinal association medical position statement on the management of barrett's esophagus. Gastroenterology 2011, 140:1084-91. 10.1053/j.gastro.2011.01.030.
42. Park KK, Tung RC, de Luzuiaga AR. Painful parotid hypertrophy with bulimia: a report of medical management. J Drugs Dermatol 2009, 8:577-9. 19537384.
43. Bellomo-Brandao MA, Collares EF, Da-Costa-Pinto EA. Use of erythromycin for the treatment of severe chronic constipation in children. Braz J Med Biol Res 2003, 36:1391-6. 10.1590/S0100-879X2003001000016, 14502372.
44. Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid-base disturbances. N Engl J Med 2014, 371:1434-45. 10.1056/NEJMra1003327, 25295502.
45. Mascolo M, Trent S, Colwell C, Mehler PS. What the emergency department needs to know when caring for your patients with eating disorders. Int J Eat Disord 2012, 45:977-81. 10.1002/eat.22035, 22707235.
46. Trent SA, Moreira ME, Colwell CB, Mehler PS. Emergency department management of patients with eating disorders. Am J Emerg Med 2013, 31:859-65. 10.1016/j.ajem.2013.02.035, 23623238.
47. Narayanan V, Gaudiani JL, Mehler PS. Serum albumin levels may not correlate with weight status in severe anorexia nervosa. Eat Disord 2009, 17:322-6. 10.1080/10640260902991202, 19548148.
48. Aliti GB, Rabelo ER, Clausell N, Rohde LE, Brolo A, Beck-da-Silva L. Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial. JAMA Intern Med 2013, 24:1058-64. 10.1001/jamainternmed.2013.552.
49. Mori T, Kurumazuka D, Matsumooto C, Shirakawa H, Kimura S, Kitada K, et al. Dietary salt restriction activates mineralocorticoid receptor signalling in volume-overloaded heart failure. Eur J Pharmacol 2009, 25:84-8. 10.1016/j.ejphar.2009.09.005.